Additionally, SGLT1/2 inhibitors reduce renal glucose reabsorption, leading to glucosuria (48), as the concentration of glucose in the urinary environment rises, Candida albicans, the primary pathogen in diabetic patients, proliferates rapidly, contributing to the development of genital fungal infections. The gene discussed is SLC5A1; the disease is Glycosuria.